Screener
Trevi Therapeutics, Inc. TRVI EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
FAQ
- What is Trevi Therapeutics, Inc.'s EPS (basic)?
- Trevi Therapeutics, Inc. (TRVI) reported EPS (basic) of -$0.09 in Q1 2026.
- How has Trevi Therapeutics, Inc.'s EPS (basic) changed year-over-year?
- Trevi Therapeutics, Inc.'s EPS (basic) decreased by 0.0% year-over-year, from -$0.09 to -$0.09.
- What is the long-term trend for Trevi Therapeutics, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s EPS (basic) has grown at a -31.9% compound annual growth rate (CAGR), from -$1.49 to -$0.32.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Trevi Therapeutics, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude